nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—migraine—Prednisone—prostate cancer	0.111	0.508	CpDpCtD
Indomethacin—osteoarthritis—Prednisone—prostate cancer	0.108	0.492	CpDpCtD
Indomethacin—AKR1C3—prostate cancer	0.086	0.342	CbGaD
Indomethacin—PPARA—prostate cancer	0.0745	0.297	CbGaD
Indomethacin—CXCL8—prostate cancer	0.0517	0.206	CbGaD
Indomethacin—ABCC11—Conjugated Estrogens—prostate cancer	0.0321	0.0968	CbGbCtD
Indomethacin—CYP2C19—prostate cancer	0.0242	0.0963	CbGaD
Indomethacin—SLC10A1—Ethinyl Estradiol—prostate cancer	0.0217	0.0654	CbGbCtD
Indomethacin—SLC10A1—Conjugated Estrogens—prostate cancer	0.0159	0.048	CbGbCtD
Indomethacin—CES1—Capecitabine—prostate cancer	0.0155	0.0465	CbGbCtD
Indomethacin—PTGS2—prostate cancer	0.0151	0.06	CbGaD
Indomethacin—ABCC1—Abiraterone—prostate cancer	0.0115	0.0347	CbGbCtD
Indomethacin—ABCC6—Etoposide—prostate cancer	0.0106	0.0319	CbGbCtD
Indomethacin—AKR1C3—Doxorubicin—prostate cancer	0.0096	0.0289	CbGbCtD
Indomethacin—ABCC3—Conjugated Estrogens—prostate cancer	0.00887	0.0267	CbGbCtD
Indomethacin—SLCO1A2—Estrone—prostate cancer	0.00743	0.0224	CbGbCtD
Indomethacin—SLC22A11—Conjugated Estrogens—prostate cancer	0.00728	0.0219	CbGbCtD
Indomethacin—ABCC6—Doxorubicin—prostate cancer	0.00721	0.0217	CbGbCtD
Indomethacin—SLCO1B1—Cabazitaxel—prostate cancer	0.00717	0.0216	CbGbCtD
Indomethacin—SLCO1B1—Estrone—prostate cancer	0.00701	0.0211	CbGbCtD
Indomethacin—ABCC4—Conjugated Estrogens—prostate cancer	0.00677	0.0204	CbGbCtD
Indomethacin—SLC22A11—Estradiol—prostate cancer	0.00639	0.0192	CbGbCtD
Indomethacin—UGT1A1—Estradiol—prostate cancer	0.00581	0.0175	CbGbCtD
Indomethacin—UGT2B7—Epirubicin—prostate cancer	0.00564	0.017	CbGbCtD
Indomethacin—ABCC2—Ethinyl Estradiol—prostate cancer	0.00549	0.0165	CbGbCtD
Indomethacin—ABCC1—Conjugated Estrogens—prostate cancer	0.00544	0.0164	CbGbCtD
Indomethacin—ALB—Abiraterone—prostate cancer	0.00531	0.016	CbGbCtD
Indomethacin—ABCC3—Etoposide—prostate cancer	0.00508	0.0153	CbGbCtD
Indomethacin—ABCC1—Mitoxantrone—prostate cancer	0.00495	0.0149	CbGbCtD
Indomethacin—SLCO1A2—Conjugated Estrogens—prostate cancer	0.00486	0.0146	CbGbCtD
Indomethacin—SLCO1B1—Conjugated Estrogens—prostate cancer	0.00459	0.0138	CbGbCtD
Indomethacin—SLCO1A2—Estradiol—prostate cancer	0.00427	0.0129	CbGbCtD
Indomethacin—SLC22A8—Conjugated Estrogens—prostate cancer	0.00423	0.0127	CbGbCtD
Indomethacin—CYP2C19—Nilutamide—prostate cancer	0.00415	0.0125	CbGbCtD
Indomethacin—CYP2C19—Bicalutamide—prostate cancer	0.00415	0.0125	CbGbCtD
Indomethacin—ABCC2—Conjugated Estrogens—prostate cancer	0.00403	0.0121	CbGbCtD
Indomethacin—SLCO1B1—Estradiol—prostate cancer	0.00403	0.0121	CbGbCtD
Indomethacin—ABCC1—Epirubicin—prostate cancer	0.004	0.0121	CbGbCtD
Indomethacin—ALB—Estrone—prostate cancer	0.00384	0.0116	CbGbCtD
Indomethacin—UGT1A1—Etoposide—prostate cancer	0.0038	0.0114	CbGbCtD
Indomethacin—SLC22A8—Estradiol—prostate cancer	0.00372	0.0112	CbGbCtD
Indomethacin—SLCO1A2—Prednisone—prostate cancer	0.00367	0.0111	CbGbCtD
Indomethacin—SLC22A7—Docetaxel—prostate cancer	0.00364	0.011	CbGbCtD
Indomethacin—ABCC3—Doxorubicin—prostate cancer	0.00347	0.0104	CbGbCtD
Indomethacin—CYP2C9—Nilutamide—prostate cancer	0.00345	0.0104	CbGbCtD
Indomethacin—CYP2C9—Bicalutamide—prostate cancer	0.00345	0.0104	CbGbCtD
Indomethacin—CYP2C19—Flutamide—prostate cancer	0.00344	0.0104	CbGbCtD
Indomethacin—ABCC1—Etoposide—prostate cancer	0.00312	0.0094	CbGbCtD
Indomethacin—ABCB1—Estramustine—prostate cancer	0.00312	0.00938	CbGbCtD
Indomethacin—SLC22A6—Conjugated Estrogens—prostate cancer	0.00295	0.00888	CbGbCtD
Indomethacin—ABCC1—Docetaxel—prostate cancer	0.00285	0.0086	CbGbCtD
Indomethacin—ABCC2—Etoposide—prostate cancer	0.00231	0.00696	CbGbCtD
Indomethacin—PTGS2—Etoposide—prostate cancer	0.00228	0.00687	CbGbCtD
Indomethacin—ALB—Estradiol—prostate cancer	0.0022	0.00664	CbGbCtD
Indomethacin—ABCC1—Doxorubicin—prostate cancer	0.00213	0.00641	CbGbCtD
Indomethacin—ABCC2—Docetaxel—prostate cancer	0.00211	0.00636	CbGbCtD
Indomethacin—CYP2C9—Estrone—prostate cancer	0.00207	0.00623	CbGbCtD
Indomethacin—ABCB1—Cabazitaxel—prostate cancer	0.00205	0.00619	CbGbCtD
Indomethacin—ABCB1—Estrone—prostate cancer	0.00201	0.00605	CbGbCtD
Indomethacin—PTGS1—Etoposide—prostate cancer	0.00193	0.00581	CbGbCtD
Indomethacin—ALB—Prednisone—prostate cancer	0.0019	0.00571	CbGbCtD
Indomethacin—ABCB1—Ethinyl Estradiol—prostate cancer	0.00179	0.00539	CbGbCtD
Indomethacin—ABCC2—Doxorubicin—prostate cancer	0.00158	0.00474	CbGbCtD
Indomethacin—CYP2C9—Capecitabine—prostate cancer	0.00157	0.00472	CbGbCtD
Indomethacin—CYP2C19—Estradiol—prostate cancer	0.00143	0.0043	CbGbCtD
Indomethacin—ABCB1—Conjugated Estrogens—prostate cancer	0.00131	0.00396	CbGbCtD
Indomethacin—UGT1A1—urine—prostate cancer	0.00131	0.0367	CbGeAlD
Indomethacin—CYP2C19—Prednisone—prostate cancer	0.00123	0.0037	CbGbCtD
Indomethacin—ABCB1—Mitoxantrone—prostate cancer	0.00119	0.0036	CbGbCtD
Indomethacin—CYP2C9—Estradiol—prostate cancer	0.00119	0.00358	CbGbCtD
Indomethacin—ABCB1—Estradiol—prostate cancer	0.00115	0.00347	CbGbCtD
Indomethacin—PTGR2—prostate gland—prostate cancer	0.00114	0.032	CbGeAlD
Indomethacin—ABCB1—Prednisone—prostate cancer	0.000992	0.00299	CbGbCtD
Indomethacin—PTGR2—seminal vesicle—prostate cancer	0.000966	0.0271	CbGeAlD
Indomethacin—SLC22A8—urine—prostate cancer	0.000845	0.0237	CbGeAlD
Indomethacin—PTGR2—renal system—prostate cancer	0.000778	0.0218	CbGeAlD
Indomethacin—PTGR2—urethra—prostate cancer	0.000765	0.0214	CbGeAlD
Indomethacin—ABCB1—Etoposide—prostate cancer	0.000753	0.00227	CbGbCtD
Indomethacin—CYP2C19—urine—prostate cancer	0.000709	0.0199	CbGeAlD
Indomethacin—GLO1—prostate gland—prostate cancer	0.000705	0.0198	CbGeAlD
Indomethacin—ABCB1—Docetaxel—prostate cancer	0.000689	0.00207	CbGbCtD
Indomethacin—PLA2G2A—prostate gland—prostate cancer	0.000656	0.0184	CbGeAlD
Indomethacin—CXCL8—prostate gland—prostate cancer	0.000649	0.0182	CbGeAlD
Indomethacin—PPARA—prostate gland—prostate cancer	0.000613	0.0172	CbGeAlD
Indomethacin—GLO1—seminal vesicle—prostate cancer	0.000597	0.0167	CbGeAlD
Indomethacin—SLC10A1—prostate gland—prostate cancer	0.000589	0.0165	CbGeAlD
Indomethacin—PLA2G2A—seminal vesicle—prostate cancer	0.000555	0.0156	CbGeAlD
Indomethacin—UGT2B7—prostate gland—prostate cancer	0.000552	0.0155	CbGeAlD
Indomethacin—CYP2C9—urine—prostate cancer	0.00055	0.0154	CbGeAlD
Indomethacin—Fenofibrate—PPARA—prostate cancer	0.000527	0.272	CrCbGaD
Indomethacin—GLO1—epithelium—prostate cancer	0.000518	0.0145	CbGeAlD
Indomethacin—ABCB1—Doxorubicin—prostate cancer	0.000514	0.00155	CbGbCtD
Indomethacin—AKR1C3—prostate gland—prostate cancer	0.000509	0.0143	CbGeAlD
Indomethacin—PTGR2—testis—prostate cancer	0.000503	0.0141	CbGeAlD
Indomethacin—SLC10A1—seminal vesicle—prostate cancer	0.000498	0.014	CbGeAlD
Indomethacin—ABCC11—testis—prostate cancer	0.000498	0.014	CbGeAlD
Indomethacin—ABCC6—Podofilox—Etoposide—prostate cancer	0.000496	0.434	CbGdCrCtD
Indomethacin—PLA2G2A—epithelium—prostate cancer	0.000482	0.0135	CbGeAlD
Indomethacin—GLO1—renal system—prostate cancer	0.000481	0.0135	CbGeAlD
Indomethacin—GLO1—urethra—prostate cancer	0.000472	0.0132	CbGeAlD
Indomethacin—UGT1A1—prostate gland—prostate cancer	0.000469	0.0132	CbGeAlD
Indomethacin—UGT1A9—renal system—prostate cancer	0.000467	0.0131	CbGeAlD
Indomethacin—CES1—prostate gland—prostate cancer	0.000455	0.0127	CbGeAlD
Indomethacin—PPARA—epithelium—prostate cancer	0.00045	0.0126	CbGeAlD
Indomethacin—PLA2G2A—renal system—prostate cancer	0.000447	0.0125	CbGeAlD
Indomethacin—ABCC6—renal system—prostate cancer	0.000443	0.0124	CbGeAlD
Indomethacin—PLA2G2A—urethra—prostate cancer	0.000439	0.0123	CbGeAlD
Indomethacin—CXCL8—urethra—prostate cancer	0.000435	0.0122	CbGeAlD
Indomethacin—AKR1C3—Podofilox—Etoposide—prostate cancer	0.000433	0.379	CbGdCrCtD
Indomethacin—AKR1C3—seminal vesicle—prostate cancer	0.000431	0.0121	CbGeAlD
Indomethacin—PPARA—renal system—prostate cancer	0.000418	0.0117	CbGeAlD
Indomethacin—SLC10A1—renal system—prostate cancer	0.000402	0.0113	CbGeAlD
Indomethacin—UGT2B7—renal system—prostate cancer	0.000376	0.0106	CbGeAlD
Indomethacin—ABCC3—prostate gland—prostate cancer	0.000371	0.0104	CbGeAlD
Indomethacin—SLC22A11—renal system—prostate cancer	0.000367	0.0103	CbGeAlD
Indomethacin—PTGR2—lymph node—prostate cancer	0.000365	0.0102	CbGeAlD
Indomethacin—GLO1—bone marrow—prostate cancer	0.000364	0.0102	CbGeAlD
Indomethacin—SLC22A7—renal system—prostate cancer	0.000358	0.01	CbGeAlD
Indomethacin—AKR1C3—urethra—prostate cancer	0.000341	0.00956	CbGeAlD
Indomethacin—PPARG—prostate gland—prostate cancer	0.000337	0.00945	CbGeAlD
Indomethacin—CXCL8—bone marrow—prostate cancer	0.000335	0.00938	CbGeAlD
Indomethacin—UGT1A1—renal system—prostate cancer	0.00032	0.00897	CbGeAlD
Indomethacin—GLO1—testis—prostate cancer	0.000311	0.00871	CbGeAlD
Indomethacin—ABCC4—prostate gland—prostate cancer	0.000306	0.00858	CbGeAlD
Indomethacin—SLC22A8—prostate gland—prostate cancer	0.000303	0.00851	CbGeAlD
Indomethacin—ABCC2—prostate gland—prostate cancer	0.000296	0.0083	CbGeAlD
Indomethacin—PLA2G2A—testis—prostate cancer	0.000289	0.0081	CbGeAlD
Indomethacin—CXCL8—testis—prostate cancer	0.000286	0.00802	CbGeAlD
Indomethacin—Naproxen—AKR1C3—prostate cancer	0.000281	0.145	CrCbGaD
Indomethacin—PPARA—testis—prostate cancer	0.00027	0.00757	CbGeAlD
Indomethacin—Bezafibrate—PPARA—prostate cancer	0.000267	0.138	CrCbGaD
Indomethacin—SLCO1B1—renal system—prostate cancer	0.000266	0.00746	CbGeAlD
Indomethacin—AKR1C3—bone marrow—prostate cancer	0.000262	0.00736	CbGeAlD
Indomethacin—ABCC1—prostate gland—prostate cancer	0.000261	0.00731	CbGeAlD
Indomethacin—SLC10A1—testis—prostate cancer	0.00026	0.00728	CbGeAlD
Indomethacin—ABCC3—renal system—prostate cancer	0.000253	0.00708	CbGeAlD
Indomethacin—PPARG—epithelium—prostate cancer	0.000248	0.00694	CbGeAlD
Indomethacin—UGT2B7—testis—prostate cancer	0.000243	0.00682	CbGeAlD
Indomethacin—SLC22A7—testis—prostate cancer	0.000231	0.00649	CbGeAlD
Indomethacin—PPARG—renal system—prostate cancer	0.00023	0.00644	CbGeAlD
Indomethacin—PPARG—urethra—prostate cancer	0.000226	0.00632	CbGeAlD
Indomethacin—GLO1—lymph node—prostate cancer	0.000225	0.00632	CbGeAlD
Indomethacin—Tolmetin—CXCL8—prostate cancer	0.000225	0.116	CrCbGaD
Indomethacin—AKR1C3—testis—prostate cancer	0.000224	0.00629	CbGeAlD
Indomethacin—ABCC1—seminal vesicle—prostate cancer	0.000221	0.00619	CbGeAlD
Indomethacin—SLCO1A2—renal system—prostate cancer	0.000217	0.00607	CbGeAlD
Indomethacin—PPARG—Teniposide—Etoposide—prostate cancer	0.000213	0.187	CbGdCrCtD
Indomethacin—PLA2G2A—lymph node—prostate cancer	0.000209	0.00587	CbGeAlD
Indomethacin—ABCC4—renal system—prostate cancer	0.000208	0.00585	CbGeAlD
Indomethacin—CXCL8—lymph node—prostate cancer	0.000207	0.00581	CbGeAlD
Indomethacin—SLC22A8—renal system—prostate cancer	0.000207	0.0058	CbGeAlD
Indomethacin—ABCC2—renal system—prostate cancer	0.000202	0.00566	CbGeAlD
Indomethacin—CES1—testis—prostate cancer	0.0002	0.00562	CbGeAlD
Indomethacin—PPARA—lymph node—prostate cancer	0.000196	0.00549	CbGeAlD
Indomethacin—PTGS1—prostate gland—prostate cancer	0.00018	0.00505	CbGeAlD
Indomethacin—Tolmetin—MPO—prostate cancer	0.000175	0.0903	CrCbGaD
Indomethacin—ABCC1—urethra—prostate cancer	0.000175	0.0049	CbGeAlD
Indomethacin—PPARG—bone marrow—prostate cancer	0.000174	0.00487	CbGeAlD
Indomethacin—PTGS2—prostate gland—prostate cancer	0.000172	0.00483	CbGeAlD
Indomethacin—ABCC3—testis—prostate cancer	0.000163	0.00458	CbGeAlD
Indomethacin—AKR1C3—lymph node—prostate cancer	0.000163	0.00456	CbGeAlD
Indomethacin—ABCC4—bone marrow—prostate cancer	0.000158	0.00442	CbGeAlD
Indomethacin—PTGS1—seminal vesicle—prostate cancer	0.000152	0.00427	CbGeAlD
Indomethacin—PPARG—testis—prostate cancer	0.000148	0.00416	CbGeAlD
Indomethacin—PTGS2—seminal vesicle—prostate cancer	0.000146	0.00408	CbGeAlD
Indomethacin—CES1—lymph node—prostate cancer	0.000145	0.00407	CbGeAlD
Indomethacin—SLCO1A2—testis—prostate cancer	0.00014	0.00393	CbGeAlD
Indomethacin—ALB—testis—prostate cancer	0.000139	0.0039	CbGeAlD
Indomethacin—ABCC4—testis—prostate cancer	0.000135	0.00378	CbGeAlD
Indomethacin—PTGS1—epithelium—prostate cancer	0.000132	0.00371	CbGeAlD
Indomethacin—ABCC2—testis—prostate cancer	0.00013	0.00366	CbGeAlD
Indomethacin—PTGS2—epithelium—prostate cancer	0.000126	0.00355	CbGeAlD
Indomethacin—PTGS1—renal system—prostate cancer	0.000123	0.00344	CbGeAlD
Indomethacin—ABCC3—lymph node—prostate cancer	0.000118	0.00332	CbGeAlD
Indomethacin—PTGS2—renal system—prostate cancer	0.000117	0.00329	CbGeAlD
Indomethacin—PTGS2—urethra—prostate cancer	0.000115	0.00323	CbGeAlD
Indomethacin—ABCC1—testis—prostate cancer	0.000115	0.00322	CbGeAlD
Indomethacin—Fenofibrate—CYP3A4—prostate cancer	0.000109	0.0562	CrCbGaD
Indomethacin—PPARG—lymph node—prostate cancer	0.000108	0.00302	CbGeAlD
Indomethacin—ABCB1—prostate gland—prostate cancer	0.000106	0.00299	CbGeAlD
Indomethacin—ALB—lymph node—prostate cancer	0.000101	0.00283	CbGeAlD
Indomethacin—ABCC4—lymph node—prostate cancer	9.77e-05	0.00274	CbGeAlD
Indomethacin—Bromfenac—PTGS2—prostate cancer	9.75e-05	0.0503	CrCbGaD
Indomethacin—ABCC2—lymph node—prostate cancer	9.46e-05	0.00265	CbGeAlD
Indomethacin—ABCB1—seminal vesicle—prostate cancer	9.01e-05	0.00253	CbGeAlD
Indomethacin—PTGS2—bone marrow—prostate cancer	8.87e-05	0.00249	CbGeAlD
Indomethacin—Bezafibrate—CYP1A1—prostate cancer	8.62e-05	0.0445	CrCbGaD
Indomethacin—ABCC1—lymph node—prostate cancer	8.33e-05	0.00234	CbGeAlD
Indomethacin—PTGS1—testis—prostate cancer	7.93e-05	0.00222	CbGeAlD
Indomethacin—ABCB1—epithelium—prostate cancer	7.82e-05	0.00219	CbGeAlD
Indomethacin—ABCB1—renal system—prostate cancer	7.26e-05	0.00204	CbGeAlD
Indomethacin—ABCB1—urethra—prostate cancer	7.13e-05	0.002	CbGeAlD
Indomethacin—Tolmetin—PTGS2—prostate cancer	6.55e-05	0.0338	CrCbGaD
Indomethacin—PTGS1—lymph node—prostate cancer	5.75e-05	0.00161	CbGeAlD
Indomethacin—Bezafibrate—CYP3A4—prostate cancer	5.5e-05	0.0284	CrCbGaD
Indomethacin—PTGS2—lymph node—prostate cancer	5.5e-05	0.00154	CbGeAlD
Indomethacin—ABCB1—bone marrow—prostate cancer	5.49e-05	0.00154	CbGeAlD
Indomethacin—Naproxen—PTGS2—prostate cancer	4.93e-05	0.0255	CrCbGaD
Indomethacin—ABCB1—testis—prostate cancer	4.69e-05	0.00132	CbGeAlD
Indomethacin—ABCB1—lymph node—prostate cancer	3.4e-05	0.000953	CbGeAlD
Indomethacin—Gastrointestinal pain—Etoposide—prostate cancer	2.05e-05	0.000248	CcSEcCtD
Indomethacin—Shock—Docetaxel—prostate cancer	2.05e-05	0.000248	CcSEcCtD
Indomethacin—Ill-defined disorder—Prednisone—prostate cancer	2.04e-05	0.000247	CcSEcCtD
Indomethacin—Thrombocytopenia—Docetaxel—prostate cancer	2.04e-05	0.000247	CcSEcCtD
Indomethacin—Rash—Estradiol—prostate cancer	2.04e-05	0.000247	CcSEcCtD
Indomethacin—Drowsiness—Doxorubicin—prostate cancer	2.04e-05	0.000247	CcSEcCtD
Indomethacin—Dermatitis—Estradiol—prostate cancer	2.03e-05	0.000247	CcSEcCtD
Indomethacin—Anaemia—Prednisone—prostate cancer	2.03e-05	0.000246	CcSEcCtD
Indomethacin—Confusional state—Capecitabine—prostate cancer	2.03e-05	0.000246	CcSEcCtD
Indomethacin—Tachycardia—Docetaxel—prostate cancer	2.03e-05	0.000246	CcSEcCtD
Indomethacin—Headache—Estradiol—prostate cancer	2.02e-05	0.000245	CcSEcCtD
Indomethacin—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	2.02e-05	0.000245	CcSEcCtD
Indomethacin—Oedema—Capecitabine—prostate cancer	2.01e-05	0.000244	CcSEcCtD
Indomethacin—Bradycardia—Epirubicin—prostate cancer	2.01e-05	0.000244	CcSEcCtD
Indomethacin—Angioedema—Prednisone—prostate cancer	2.01e-05	0.000244	CcSEcCtD
Indomethacin—Renal failure—Doxorubicin—prostate cancer	2e-05	0.000243	CcSEcCtD
Indomethacin—Neuropathy peripheral—Doxorubicin—prostate cancer	2e-05	0.000242	CcSEcCtD
Indomethacin—Urticaria—Etoposide—prostate cancer	1.99e-05	0.000241	CcSEcCtD
Indomethacin—Haemoglobin—Epirubicin—prostate cancer	1.98e-05	0.000241	CcSEcCtD
Indomethacin—Jaundice—Doxorubicin—prostate cancer	1.98e-05	0.000241	CcSEcCtD
Indomethacin—Stomatitis—Doxorubicin—prostate cancer	1.98e-05	0.000241	CcSEcCtD
Indomethacin—Anorexia—Docetaxel—prostate cancer	1.98e-05	0.00024	CcSEcCtD
Indomethacin—Malaise—Prednisone—prostate cancer	1.98e-05	0.00024	CcSEcCtD
Indomethacin—Shock—Capecitabine—prostate cancer	1.98e-05	0.00024	CcSEcCtD
Indomethacin—Body temperature increased—Etoposide—prostate cancer	1.98e-05	0.00024	CcSEcCtD
Indomethacin—Abdominal pain—Etoposide—prostate cancer	1.98e-05	0.00024	CcSEcCtD
Indomethacin—Vertigo—Prednisone—prostate cancer	1.97e-05	0.00024	CcSEcCtD
Indomethacin—Haemorrhage—Epirubicin—prostate cancer	1.97e-05	0.00024	CcSEcCtD
Indomethacin—Hepatitis—Epirubicin—prostate cancer	1.97e-05	0.00024	CcSEcCtD
Indomethacin—Thrombocytopenia—Capecitabine—prostate cancer	1.97e-05	0.000239	CcSEcCtD
Indomethacin—Syncope—Prednisone—prostate cancer	1.97e-05	0.000239	CcSEcCtD
Indomethacin—Tachycardia—Capecitabine—prostate cancer	1.97e-05	0.000238	CcSEcCtD
Indomethacin—Sweating—Doxorubicin—prostate cancer	1.95e-05	0.000237	CcSEcCtD
Indomethacin—Hyperhidrosis—Capecitabine—prostate cancer	1.95e-05	0.000236	CcSEcCtD
Indomethacin—Hypotension—Docetaxel—prostate cancer	1.94e-05	0.000236	CcSEcCtD
Indomethacin—Haematuria—Doxorubicin—prostate cancer	1.94e-05	0.000235	CcSEcCtD
Indomethacin—Loss of consciousness—Prednisone—prostate cancer	1.93e-05	0.000234	CcSEcCtD
Indomethacin—Epistaxis—Doxorubicin—prostate cancer	1.92e-05	0.000233	CcSEcCtD
Indomethacin—Anorexia—Capecitabine—prostate cancer	1.92e-05	0.000233	CcSEcCtD
Indomethacin—Nausea—Estradiol—prostate cancer	1.92e-05	0.000233	CcSEcCtD
Indomethacin—Vomiting—Mitoxantrone—prostate cancer	1.91e-05	0.000232	CcSEcCtD
Indomethacin—Convulsion—Prednisone—prostate cancer	1.9e-05	0.000231	CcSEcCtD
Indomethacin—Agranulocytosis—Doxorubicin—prostate cancer	1.9e-05	0.00023	CcSEcCtD
Indomethacin—Hypertension—Prednisone—prostate cancer	1.9e-05	0.00023	CcSEcCtD
Indomethacin—Rash—Mitoxantrone—prostate cancer	1.9e-05	0.00023	CcSEcCtD
Indomethacin—Dermatitis—Mitoxantrone—prostate cancer	1.9e-05	0.00023	CcSEcCtD
Indomethacin—Headache—Mitoxantrone—prostate cancer	1.89e-05	0.000229	CcSEcCtD
Indomethacin—Hypotension—Capecitabine—prostate cancer	1.88e-05	0.000228	CcSEcCtD
Indomethacin—Insomnia—Docetaxel—prostate cancer	1.88e-05	0.000228	CcSEcCtD
Indomethacin—Paraesthesia—Docetaxel—prostate cancer	1.87e-05	0.000227	CcSEcCtD
Indomethacin—Erythema multiforme—Epirubicin—prostate cancer	1.87e-05	0.000226	CcSEcCtD
Indomethacin—Anxiety—Prednisone—prostate cancer	1.86e-05	0.000226	CcSEcCtD
Indomethacin—Bradycardia—Doxorubicin—prostate cancer	1.86e-05	0.000226	CcSEcCtD
Indomethacin—Dyspnoea—Docetaxel—prostate cancer	1.85e-05	0.000225	CcSEcCtD
Indomethacin—Somnolence—Docetaxel—prostate cancer	1.85e-05	0.000224	CcSEcCtD
Indomethacin—Discomfort—Prednisone—prostate cancer	1.85e-05	0.000224	CcSEcCtD
Indomethacin—Hypersensitivity—Etoposide—prostate cancer	1.84e-05	0.000224	CcSEcCtD
Indomethacin—Tinnitus—Epirubicin—prostate cancer	1.84e-05	0.000223	CcSEcCtD
Indomethacin—Haemoglobin—Doxorubicin—prostate cancer	1.84e-05	0.000223	CcSEcCtD
Indomethacin—Flushing—Epirubicin—prostate cancer	1.83e-05	0.000222	CcSEcCtD
Indomethacin—Dyspepsia—Docetaxel—prostate cancer	1.83e-05	0.000222	CcSEcCtD
Indomethacin—Hepatitis—Doxorubicin—prostate cancer	1.83e-05	0.000222	CcSEcCtD
Indomethacin—Haemorrhage—Doxorubicin—prostate cancer	1.83e-05	0.000222	CcSEcCtD
Indomethacin—Insomnia—Capecitabine—prostate cancer	1.82e-05	0.000221	CcSEcCtD
Indomethacin—Paraesthesia—Capecitabine—prostate cancer	1.81e-05	0.000219	CcSEcCtD
Indomethacin—Decreased appetite—Docetaxel—prostate cancer	1.81e-05	0.000219	CcSEcCtD
Indomethacin—Asthenia—Etoposide—prostate cancer	1.8e-05	0.000218	CcSEcCtD
Indomethacin—Dyspnoea—Capecitabine—prostate cancer	1.8e-05	0.000218	CcSEcCtD
Indomethacin—Oedema—Prednisone—prostate cancer	1.79e-05	0.000218	CcSEcCtD
Indomethacin—Anaphylactic shock—Prednisone—prostate cancer	1.79e-05	0.000218	CcSEcCtD
Indomethacin—Fatigue—Docetaxel—prostate cancer	1.79e-05	0.000218	CcSEcCtD
Indomethacin—Nausea—Mitoxantrone—prostate cancer	1.79e-05	0.000217	CcSEcCtD
Indomethacin—Constipation—Docetaxel—prostate cancer	1.78e-05	0.000216	CcSEcCtD
Indomethacin—Pain—Docetaxel—prostate cancer	1.78e-05	0.000216	CcSEcCtD
Indomethacin—Dyspepsia—Capecitabine—prostate cancer	1.77e-05	0.000215	CcSEcCtD
Indomethacin—Pruritus—Etoposide—prostate cancer	1.77e-05	0.000215	CcSEcCtD
Indomethacin—Shock—Prednisone—prostate cancer	1.76e-05	0.000214	CcSEcCtD
Indomethacin—Arrhythmia—Epirubicin—prostate cancer	1.76e-05	0.000214	CcSEcCtD
Indomethacin—Tachycardia—Prednisone—prostate cancer	1.75e-05	0.000212	CcSEcCtD
Indomethacin—Decreased appetite—Capecitabine—prostate cancer	1.75e-05	0.000212	CcSEcCtD
Indomethacin—Alopecia—Epirubicin—prostate cancer	1.75e-05	0.000212	CcSEcCtD
Indomethacin—Fatigue—Capecitabine—prostate cancer	1.74e-05	0.000211	CcSEcCtD
Indomethacin—Hyperhidrosis—Prednisone—prostate cancer	1.73e-05	0.00021	CcSEcCtD
Indomethacin—Erythema multiforme—Doxorubicin—prostate cancer	1.73e-05	0.00021	CcSEcCtD
Indomethacin—Pain—Capecitabine—prostate cancer	1.72e-05	0.000209	CcSEcCtD
Indomethacin—Constipation—Capecitabine—prostate cancer	1.72e-05	0.000209	CcSEcCtD
Indomethacin—Erythema—Epirubicin—prostate cancer	1.72e-05	0.000209	CcSEcCtD
Indomethacin—Feeling abnormal—Docetaxel—prostate cancer	1.71e-05	0.000208	CcSEcCtD
Indomethacin—Diarrhoea—Etoposide—prostate cancer	1.71e-05	0.000208	CcSEcCtD
Indomethacin—Anorexia—Prednisone—prostate cancer	1.71e-05	0.000207	CcSEcCtD
Indomethacin—Tinnitus—Doxorubicin—prostate cancer	1.7e-05	0.000207	CcSEcCtD
Indomethacin—Gastrointestinal pain—Docetaxel—prostate cancer	1.7e-05	0.000206	CcSEcCtD
Indomethacin—Flushing—Doxorubicin—prostate cancer	1.7e-05	0.000206	CcSEcCtD
Indomethacin—Flatulence—Epirubicin—prostate cancer	1.69e-05	0.000205	CcSEcCtD
Indomethacin—Tension—Epirubicin—prostate cancer	1.69e-05	0.000205	CcSEcCtD
Indomethacin—Nervousness—Epirubicin—prostate cancer	1.67e-05	0.000203	CcSEcCtD
Indomethacin—Feeling abnormal—Capecitabine—prostate cancer	1.66e-05	0.000201	CcSEcCtD
Indomethacin—Dizziness—Etoposide—prostate cancer	1.66e-05	0.000201	CcSEcCtD
Indomethacin—Gastrointestinal pain—Capecitabine—prostate cancer	1.65e-05	0.0002	CcSEcCtD
Indomethacin—Body temperature increased—Docetaxel—prostate cancer	1.64e-05	0.000199	CcSEcCtD
Indomethacin—Abdominal pain—Docetaxel—prostate cancer	1.64e-05	0.000199	CcSEcCtD
Indomethacin—Arrhythmia—Doxorubicin—prostate cancer	1.63e-05	0.000198	CcSEcCtD
Indomethacin—Insomnia—Prednisone—prostate cancer	1.62e-05	0.000197	CcSEcCtD
Indomethacin—Vision blurred—Epirubicin—prostate cancer	1.62e-05	0.000197	CcSEcCtD
Indomethacin—Alopecia—Doxorubicin—prostate cancer	1.61e-05	0.000196	CcSEcCtD
Indomethacin—Paraesthesia—Prednisone—prostate cancer	1.61e-05	0.000195	CcSEcCtD
Indomethacin—Urticaria—Capecitabine—prostate cancer	1.6e-05	0.000194	CcSEcCtD
Indomethacin—Ill-defined disorder—Epirubicin—prostate cancer	1.6e-05	0.000193	CcSEcCtD
Indomethacin—Body temperature increased—Capecitabine—prostate cancer	1.59e-05	0.000193	CcSEcCtD
Indomethacin—Abdominal pain—Capecitabine—prostate cancer	1.59e-05	0.000193	CcSEcCtD
Indomethacin—Vomiting—Etoposide—prostate cancer	1.59e-05	0.000193	CcSEcCtD
Indomethacin—Erythema—Doxorubicin—prostate cancer	1.59e-05	0.000193	CcSEcCtD
Indomethacin—Anaemia—Epirubicin—prostate cancer	1.59e-05	0.000193	CcSEcCtD
Indomethacin—Dyspepsia—Prednisone—prostate cancer	1.58e-05	0.000192	CcSEcCtD
Indomethacin—Rash—Etoposide—prostate cancer	1.58e-05	0.000191	CcSEcCtD
Indomethacin—Dermatitis—Etoposide—prostate cancer	1.58e-05	0.000191	CcSEcCtD
Indomethacin—Headache—Etoposide—prostate cancer	1.57e-05	0.00019	CcSEcCtD
Indomethacin—Flatulence—Doxorubicin—prostate cancer	1.57e-05	0.00019	CcSEcCtD
Indomethacin—Tension—Doxorubicin—prostate cancer	1.56e-05	0.000189	CcSEcCtD
Indomethacin—Decreased appetite—Prednisone—prostate cancer	1.56e-05	0.000189	CcSEcCtD
Indomethacin—Malaise—Epirubicin—prostate cancer	1.55e-05	0.000188	CcSEcCtD
Indomethacin—Fatigue—Prednisone—prostate cancer	1.55e-05	0.000188	CcSEcCtD
Indomethacin—Nervousness—Doxorubicin—prostate cancer	1.54e-05	0.000187	CcSEcCtD
Indomethacin—Vertigo—Epirubicin—prostate cancer	1.54e-05	0.000187	CcSEcCtD
Indomethacin—Syncope—Epirubicin—prostate cancer	1.54e-05	0.000187	CcSEcCtD
Indomethacin—Leukopenia—Epirubicin—prostate cancer	1.54e-05	0.000187	CcSEcCtD
Indomethacin—Constipation—Prednisone—prostate cancer	1.53e-05	0.000186	CcSEcCtD
Indomethacin—Hypersensitivity—Docetaxel—prostate cancer	1.53e-05	0.000186	CcSEcCtD
Indomethacin—Palpitations—Epirubicin—prostate cancer	1.52e-05	0.000184	CcSEcCtD
Indomethacin—Loss of consciousness—Epirubicin—prostate cancer	1.51e-05	0.000183	CcSEcCtD
Indomethacin—Vision blurred—Doxorubicin—prostate cancer	1.5e-05	0.000182	CcSEcCtD
Indomethacin—Asthenia—Docetaxel—prostate cancer	1.49e-05	0.000181	CcSEcCtD
Indomethacin—Convulsion—Epirubicin—prostate cancer	1.49e-05	0.000181	CcSEcCtD
Indomethacin—Nausea—Etoposide—prostate cancer	1.49e-05	0.00018	CcSEcCtD
Indomethacin—Hypertension—Epirubicin—prostate cancer	1.48e-05	0.00018	CcSEcCtD
Indomethacin—Hypersensitivity—Capecitabine—prostate cancer	1.48e-05	0.00018	CcSEcCtD
Indomethacin—Feeling abnormal—Prednisone—prostate cancer	1.48e-05	0.000179	CcSEcCtD
Indomethacin—Ill-defined disorder—Doxorubicin—prostate cancer	1.48e-05	0.000179	CcSEcCtD
Indomethacin—Pruritus—Docetaxel—prostate cancer	1.47e-05	0.000178	CcSEcCtD
Indomethacin—Anaemia—Doxorubicin—prostate cancer	1.47e-05	0.000178	CcSEcCtD
Indomethacin—Gastrointestinal pain—Prednisone—prostate cancer	1.47e-05	0.000178	CcSEcCtD
Indomethacin—Chest pain—Epirubicin—prostate cancer	1.46e-05	0.000178	CcSEcCtD
Indomethacin—Anxiety—Epirubicin—prostate cancer	1.46e-05	0.000177	CcSEcCtD
Indomethacin—Discomfort—Epirubicin—prostate cancer	1.45e-05	0.000175	CcSEcCtD
Indomethacin—Asthenia—Capecitabine—prostate cancer	1.44e-05	0.000175	CcSEcCtD
Indomethacin—Malaise—Doxorubicin—prostate cancer	1.43e-05	0.000174	CcSEcCtD
Indomethacin—Vertigo—Doxorubicin—prostate cancer	1.43e-05	0.000173	CcSEcCtD
Indomethacin—Syncope—Doxorubicin—prostate cancer	1.43e-05	0.000173	CcSEcCtD
Indomethacin—Urticaria—Prednisone—prostate cancer	1.43e-05	0.000173	CcSEcCtD
Indomethacin—Pruritus—Capecitabine—prostate cancer	1.42e-05	0.000173	CcSEcCtD
Indomethacin—Leukopenia—Doxorubicin—prostate cancer	1.42e-05	0.000173	CcSEcCtD
Indomethacin—Diarrhoea—Docetaxel—prostate cancer	1.42e-05	0.000173	CcSEcCtD
Indomethacin—Abdominal pain—Prednisone—prostate cancer	1.42e-05	0.000172	CcSEcCtD
Indomethacin—Body temperature increased—Prednisone—prostate cancer	1.42e-05	0.000172	CcSEcCtD
Indomethacin—Confusional state—Epirubicin—prostate cancer	1.41e-05	0.000172	CcSEcCtD
Indomethacin—Palpitations—Doxorubicin—prostate cancer	1.41e-05	0.00017	CcSEcCtD
Indomethacin—Oedema—Epirubicin—prostate cancer	1.4e-05	0.00017	CcSEcCtD
Indomethacin—Anaphylactic shock—Epirubicin—prostate cancer	1.4e-05	0.00017	CcSEcCtD
Indomethacin—Loss of consciousness—Doxorubicin—prostate cancer	1.4e-05	0.00017	CcSEcCtD
Indomethacin—Shock—Epirubicin—prostate cancer	1.38e-05	0.000167	CcSEcCtD
Indomethacin—Convulsion—Doxorubicin—prostate cancer	1.38e-05	0.000167	CcSEcCtD
Indomethacin—Diarrhoea—Capecitabine—prostate cancer	1.38e-05	0.000167	CcSEcCtD
Indomethacin—Dizziness—Docetaxel—prostate cancer	1.38e-05	0.000167	CcSEcCtD
Indomethacin—Thrombocytopenia—Epirubicin—prostate cancer	1.37e-05	0.000167	CcSEcCtD
Indomethacin—Hypertension—Doxorubicin—prostate cancer	1.37e-05	0.000167	CcSEcCtD
Indomethacin—Tachycardia—Epirubicin—prostate cancer	1.37e-05	0.000166	CcSEcCtD
Indomethacin—Hyperhidrosis—Epirubicin—prostate cancer	1.36e-05	0.000165	CcSEcCtD
Indomethacin—Chest pain—Doxorubicin—prostate cancer	1.35e-05	0.000164	CcSEcCtD
Indomethacin—Anxiety—Doxorubicin—prostate cancer	1.35e-05	0.000164	CcSEcCtD
Indomethacin—Discomfort—Doxorubicin—prostate cancer	1.34e-05	0.000162	CcSEcCtD
Indomethacin—Anorexia—Epirubicin—prostate cancer	1.34e-05	0.000162	CcSEcCtD
Indomethacin—Dizziness—Capecitabine—prostate cancer	1.33e-05	0.000162	CcSEcCtD
Indomethacin—Vomiting—Docetaxel—prostate cancer	1.32e-05	0.00016	CcSEcCtD
Indomethacin—Hypersensitivity—Prednisone—prostate cancer	1.32e-05	0.00016	CcSEcCtD
Indomethacin—Rash—Docetaxel—prostate cancer	1.31e-05	0.000159	CcSEcCtD
Indomethacin—Hypotension—Epirubicin—prostate cancer	1.31e-05	0.000159	CcSEcCtD
Indomethacin—Dermatitis—Docetaxel—prostate cancer	1.31e-05	0.000159	CcSEcCtD
Indomethacin—Confusional state—Doxorubicin—prostate cancer	1.31e-05	0.000159	CcSEcCtD
Indomethacin—Headache—Docetaxel—prostate cancer	1.3e-05	0.000158	CcSEcCtD
Indomethacin—Oedema—Doxorubicin—prostate cancer	1.3e-05	0.000157	CcSEcCtD
Indomethacin—Anaphylactic shock—Doxorubicin—prostate cancer	1.3e-05	0.000157	CcSEcCtD
Indomethacin—Asthenia—Prednisone—prostate cancer	1.29e-05	0.000156	CcSEcCtD
Indomethacin—Vomiting—Capecitabine—prostate cancer	1.28e-05	0.000155	CcSEcCtD
Indomethacin—Shock—Doxorubicin—prostate cancer	1.28e-05	0.000155	CcSEcCtD
Indomethacin—Thrombocytopenia—Doxorubicin—prostate cancer	1.27e-05	0.000154	CcSEcCtD
Indomethacin—Rash—Capecitabine—prostate cancer	1.27e-05	0.000154	CcSEcCtD
Indomethacin—Pruritus—Prednisone—prostate cancer	1.27e-05	0.000154	CcSEcCtD
Indomethacin—Insomnia—Epirubicin—prostate cancer	1.27e-05	0.000154	CcSEcCtD
Indomethacin—Dermatitis—Capecitabine—prostate cancer	1.27e-05	0.000154	CcSEcCtD
Indomethacin—Tachycardia—Doxorubicin—prostate cancer	1.27e-05	0.000154	CcSEcCtD
Indomethacin—Headache—Capecitabine—prostate cancer	1.26e-05	0.000153	CcSEcCtD
Indomethacin—Paraesthesia—Epirubicin—prostate cancer	1.26e-05	0.000153	CcSEcCtD
Indomethacin—Hyperhidrosis—Doxorubicin—prostate cancer	1.26e-05	0.000152	CcSEcCtD
Indomethacin—Dyspnoea—Epirubicin—prostate cancer	1.25e-05	0.000152	CcSEcCtD
Indomethacin—Somnolence—Epirubicin—prostate cancer	1.25e-05	0.000151	CcSEcCtD
Indomethacin—Anorexia—Doxorubicin—prostate cancer	1.24e-05	0.00015	CcSEcCtD
Indomethacin—Nausea—Docetaxel—prostate cancer	1.24e-05	0.00015	CcSEcCtD
Indomethacin—Dyspepsia—Epirubicin—prostate cancer	1.24e-05	0.00015	CcSEcCtD
Indomethacin—Diarrhoea—Prednisone—prostate cancer	1.23e-05	0.000149	CcSEcCtD
Indomethacin—Decreased appetite—Epirubicin—prostate cancer	1.22e-05	0.000148	CcSEcCtD
Indomethacin—Hypotension—Doxorubicin—prostate cancer	1.21e-05	0.000147	CcSEcCtD
Indomethacin—Fatigue—Epirubicin—prostate cancer	1.21e-05	0.000147	CcSEcCtD
Indomethacin—Pain—Epirubicin—prostate cancer	1.2e-05	0.000146	CcSEcCtD
Indomethacin—Constipation—Epirubicin—prostate cancer	1.2e-05	0.000146	CcSEcCtD
Indomethacin—Nausea—Capecitabine—prostate cancer	1.2e-05	0.000145	CcSEcCtD
Indomethacin—Dizziness—Prednisone—prostate cancer	1.19e-05	0.000144	CcSEcCtD
Indomethacin—Insomnia—Doxorubicin—prostate cancer	1.17e-05	0.000142	CcSEcCtD
Indomethacin—Paraesthesia—Doxorubicin—prostate cancer	1.17e-05	0.000141	CcSEcCtD
Indomethacin—Dyspnoea—Doxorubicin—prostate cancer	1.16e-05	0.00014	CcSEcCtD
Indomethacin—Feeling abnormal—Epirubicin—prostate cancer	1.16e-05	0.00014	CcSEcCtD
Indomethacin—Somnolence—Doxorubicin—prostate cancer	1.15e-05	0.00014	CcSEcCtD
Indomethacin—Gastrointestinal pain—Epirubicin—prostate cancer	1.15e-05	0.000139	CcSEcCtD
Indomethacin—Dyspepsia—Doxorubicin—prostate cancer	1.14e-05	0.000139	CcSEcCtD
Indomethacin—Vomiting—Prednisone—prostate cancer	1.14e-05	0.000138	CcSEcCtD
Indomethacin—Rash—Prednisone—prostate cancer	1.13e-05	0.000137	CcSEcCtD
Indomethacin—Dermatitis—Prednisone—prostate cancer	1.13e-05	0.000137	CcSEcCtD
Indomethacin—Decreased appetite—Doxorubicin—prostate cancer	1.13e-05	0.000137	CcSEcCtD
Indomethacin—Headache—Prednisone—prostate cancer	1.12e-05	0.000136	CcSEcCtD
Indomethacin—Fatigue—Doxorubicin—prostate cancer	1.12e-05	0.000136	CcSEcCtD
Indomethacin—Urticaria—Epirubicin—prostate cancer	1.11e-05	0.000135	CcSEcCtD
Indomethacin—Pain—Doxorubicin—prostate cancer	1.11e-05	0.000135	CcSEcCtD
Indomethacin—Constipation—Doxorubicin—prostate cancer	1.11e-05	0.000135	CcSEcCtD
Indomethacin—Abdominal pain—Epirubicin—prostate cancer	1.11e-05	0.000135	CcSEcCtD
Indomethacin—Body temperature increased—Epirubicin—prostate cancer	1.11e-05	0.000135	CcSEcCtD
Indomethacin—Feeling abnormal—Doxorubicin—prostate cancer	1.07e-05	0.00013	CcSEcCtD
Indomethacin—Nausea—Prednisone—prostate cancer	1.07e-05	0.000129	CcSEcCtD
Indomethacin—Gastrointestinal pain—Doxorubicin—prostate cancer	1.06e-05	0.000129	CcSEcCtD
Indomethacin—Hypersensitivity—Epirubicin—prostate cancer	1.03e-05	0.000125	CcSEcCtD
Indomethacin—Urticaria—Doxorubicin—prostate cancer	1.03e-05	0.000125	CcSEcCtD
Indomethacin—Abdominal pain—Doxorubicin—prostate cancer	1.03e-05	0.000124	CcSEcCtD
Indomethacin—Body temperature increased—Doxorubicin—prostate cancer	1.03e-05	0.000124	CcSEcCtD
Indomethacin—Asthenia—Epirubicin—prostate cancer	1.01e-05	0.000122	CcSEcCtD
Indomethacin—Pruritus—Epirubicin—prostate cancer	9.93e-06	0.00012	CcSEcCtD
Indomethacin—Diarrhoea—Epirubicin—prostate cancer	9.6e-06	0.000116	CcSEcCtD
Indomethacin—Hypersensitivity—Doxorubicin—prostate cancer	9.56e-06	0.000116	CcSEcCtD
Indomethacin—Asthenia—Doxorubicin—prostate cancer	9.31e-06	0.000113	CcSEcCtD
Indomethacin—Dizziness—Epirubicin—prostate cancer	9.28e-06	0.000113	CcSEcCtD
Indomethacin—Pruritus—Doxorubicin—prostate cancer	9.18e-06	0.000111	CcSEcCtD
Indomethacin—Vomiting—Epirubicin—prostate cancer	8.92e-06	0.000108	CcSEcCtD
Indomethacin—Diarrhoea—Doxorubicin—prostate cancer	8.88e-06	0.000108	CcSEcCtD
Indomethacin—Rash—Epirubicin—prostate cancer	8.85e-06	0.000107	CcSEcCtD
Indomethacin—Dermatitis—Epirubicin—prostate cancer	8.84e-06	0.000107	CcSEcCtD
Indomethacin—Headache—Epirubicin—prostate cancer	8.79e-06	0.000107	CcSEcCtD
Indomethacin—Dizziness—Doxorubicin—prostate cancer	8.58e-06	0.000104	CcSEcCtD
Indomethacin—Nausea—Epirubicin—prostate cancer	8.33e-06	0.000101	CcSEcCtD
Indomethacin—Vomiting—Doxorubicin—prostate cancer	8.25e-06	0.0001	CcSEcCtD
Indomethacin—Rash—Doxorubicin—prostate cancer	8.19e-06	9.93e-05	CcSEcCtD
Indomethacin—Dermatitis—Doxorubicin—prostate cancer	8.18e-06	9.92e-05	CcSEcCtD
Indomethacin—Headache—Doxorubicin—prostate cancer	8.13e-06	9.86e-05	CcSEcCtD
Indomethacin—Nausea—Doxorubicin—prostate cancer	7.71e-06	9.35e-05	CcSEcCtD
Indomethacin—ABCB1—Metabolism—CYP3A4—prostate cancer	6.2e-07	8.11e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CTNNB1—prostate cancer	6.17e-07	8.07e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—EP300—prostate cancer	6.15e-07	8.04e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—SLC5A5—prostate cancer	6.15e-07	8.04e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	6.14e-07	8.03e-06	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—EP300—prostate cancer	6.13e-07	8.01e-06	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—EP300—prostate cancer	6.13e-07	8.01e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CYP1B1—prostate cancer	6.09e-07	7.97e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—APC—prostate cancer	6.09e-07	7.97e-06	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—VEGFA—prostate cancer	6.09e-07	7.96e-06	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—INS—prostate cancer	6.09e-07	7.96e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—COMT—prostate cancer	6.08e-07	7.95e-06	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PTEN—prostate cancer	6.08e-07	7.95e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—MTHFR—prostate cancer	6.07e-07	7.94e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GSTP1—prostate cancer	6.05e-07	7.91e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GGT1—prostate cancer	6.05e-07	7.91e-06	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PIK3CB—prostate cancer	6.04e-07	7.9e-06	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PIK3CB—prostate cancer	6.04e-07	7.9e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CDKN1A—prostate cancer	6.03e-07	7.88e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—EGF—prostate cancer	6.02e-07	7.88e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—IRS1—prostate cancer	6.02e-07	7.88e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PTEN—prostate cancer	6.01e-07	7.86e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CYP2E1—prostate cancer	6.01e-07	7.85e-06	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—NOS3—prostate cancer	6e-07	7.84e-06	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PTGS2—prostate cancer	5.99e-07	7.83e-06	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PTGS2—prostate cancer	5.99e-07	7.83e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—SRC—prostate cancer	5.98e-07	7.82e-06	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—PIK3CA—prostate cancer	5.98e-07	7.82e-06	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—CREBBP—prostate cancer	5.96e-07	7.79e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PPARA—prostate cancer	5.96e-07	7.79e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—NCOA1—prostate cancer	5.96e-07	7.79e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—ITPR1—prostate cancer	5.95e-07	7.79e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—NQO1—prostate cancer	5.94e-07	7.77e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GGT1—prostate cancer	5.9e-07	7.72e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CYP19A1—prostate cancer	5.87e-07	7.68e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—EP300—prostate cancer	5.85e-07	7.66e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—TH—prostate cancer	5.85e-07	7.65e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—GSK3B—prostate cancer	5.85e-07	7.65e-06	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PIK3CB—prostate cancer	5.83e-07	7.62e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—VEGFA—prostate cancer	5.83e-07	7.62e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	5.81e-07	7.6e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—NCOA1—prostate cancer	5.81e-07	7.6e-06	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—EP300—prostate cancer	5.79e-07	7.58e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CYP3A4—prostate cancer	5.79e-07	7.57e-06	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PTGS2—prostate cancer	5.77e-07	7.55e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—STAT3—prostate cancer	5.77e-07	7.54e-06	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—PIK3CA—prostate cancer	5.77e-07	7.54e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—INS—prostate cancer	5.77e-07	7.54e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	5.76e-07	7.53e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—EP300—prostate cancer	5.73e-07	7.5e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CYP19A1—prostate cancer	5.73e-07	7.49e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CYP1B1—prostate cancer	5.69e-07	7.44e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—RXRA—prostate cancer	5.67e-07	7.41e-06	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PIK3CD—prostate cancer	5.65e-07	7.39e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CREBBP—prostate cancer	5.65e-07	7.39e-06	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—AKT1—prostate cancer	5.64e-07	7.37e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—TYMS—prostate cancer	5.63e-07	7.36e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CAV1—prostate cancer	5.6e-07	7.33e-06	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PTEN—prostate cancer	5.6e-07	7.32e-06	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—TGFB1—prostate cancer	5.59e-07	7.31e-06	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TP53—prostate cancer	5.58e-07	7.3e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—SRC—prostate cancer	5.58e-07	7.29e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GSTM1—prostate cancer	5.56e-07	7.27e-06	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PIK3CB—prostate cancer	5.54e-07	7.24e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—RXRA—prostate cancer	5.53e-07	7.23e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GGT1—prostate cancer	5.51e-07	7.21e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	5.51e-07	7.21e-06	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PTGS2—prostate cancer	5.49e-07	7.17e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—LPL—prostate cancer	5.46e-07	7.14e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—COMT—prostate cancer	5.46e-07	7.14e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GSTP1—prostate cancer	5.43e-07	7.1e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—NCOA1—prostate cancer	5.43e-07	7.1e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MAP2K1—prostate cancer	5.39e-07	7.05e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—STAT3—prostate cancer	5.38e-07	7.03e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MYC—prostate cancer	5.36e-07	7.01e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PIK3CD—prostate cancer	5.36e-07	7.01e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CYP19A1—prostate cancer	5.35e-07	7e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	5.35e-07	7e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TGFB1—prostate cancer	5.35e-07	6.99e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ITPR1—prostate cancer	5.34e-07	6.99e-06	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—NOS3—prostate cancer	5.34e-07	6.98e-06	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—EP300—prostate cancer	5.34e-07	6.98e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—COMT—prostate cancer	5.33e-07	6.97e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GSTP1—prostate cancer	5.3e-07	6.93e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—SERPINE1—prostate cancer	5.3e-07	6.93e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CYP1A1—prostate cancer	5.27e-07	6.89e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	5.26e-07	6.87e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—EGFR—prostate cancer	5.24e-07	6.86e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—ERCC2—prostate cancer	5.23e-07	6.84e-06	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PTEN—prostate cancer	5.22e-07	6.83e-06	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PTEN—prostate cancer	5.22e-07	6.83e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ITPR1—prostate cancer	5.22e-07	6.82e-06	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—KRAS—prostate cancer	5.18e-07	6.77e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—RXRA—prostate cancer	5.17e-07	6.76e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—FGF2—prostate cancer	5.13e-07	6.71e-06	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IL6—prostate cancer	5.11e-07	6.68e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3CG—prostate cancer	5.1e-07	6.67e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NOS3—prostate cancer	5.06e-07	6.61e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—TYMS—prostate cancer	5.05e-07	6.6e-06	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PTEN—prostate cancer	5.04e-07	6.58e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	5.02e-07	6.57e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—MYC—prostate cancer	5e-07	6.53e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GSTM1—prostate cancer	4.99e-07	6.53e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—TGFB1—prostate cancer	4.98e-07	6.52e-06	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—EP300—prostate cancer	4.98e-07	6.51e-06	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—EP300—prostate cancer	4.98e-07	6.51e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—COMT—prostate cancer	4.98e-07	6.51e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—KRAS—prostate cancer	4.95e-07	6.48e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GSTP1—prostate cancer	4.95e-07	6.48e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—TYMS—prostate cancer	4.93e-07	6.45e-06	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PIK3CB—prostate cancer	4.93e-07	6.44e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—JAK2—prostate cancer	4.92e-07	6.43e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—MTHFR—prostate cancer	4.91e-07	6.43e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—LPL—prostate cancer	4.9e-07	6.41e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—EGFR—prostate cancer	4.89e-07	6.39e-06	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—AKT1—prostate cancer	4.89e-07	6.39e-06	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PTGS2—prostate cancer	4.88e-07	6.38e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ITPR1—prostate cancer	4.87e-07	6.37e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GSTM1—prostate cancer	4.87e-07	6.37e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—INS—prostate cancer	4.83e-07	6.32e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PPARA—prostate cancer	4.82e-07	6.3e-06	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—EP300—prostate cancer	4.8e-07	6.28e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MDM2—prostate cancer	4.8e-07	6.28e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	4.79e-07	6.27e-06	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PTEN—prostate cancer	4.78e-07	6.26e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—LPL—prostate cancer	4.78e-07	6.25e-06	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—PIK3CA—prostate cancer	4.76e-07	6.22e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CYP1A1—prostate cancer	4.73e-07	6.19e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CREBBP—prostate cancer	4.73e-07	6.19e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—ERBB2—prostate cancer	4.73e-07	6.19e-06	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—AKT1—prostate cancer	4.71e-07	6.16e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ERCC2—prostate cancer	4.69e-07	6.14e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PIK3CB—prostate cancer	4.67e-07	6.11e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CYP1A1—prostate cancer	4.62e-07	6.04e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—KRAS—prostate cancer	4.62e-07	6.04e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—TYMS—prostate cancer	4.6e-07	6.02e-06	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—TP53—prostate cancer	4.6e-07	6.02e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ERCC2—prostate cancer	4.58e-07	5.99e-06	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—EP300—prostate cancer	4.56e-07	5.97e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GSTM1—prostate cancer	4.55e-07	5.95e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—PIK3CA—prostate cancer	4.55e-07	5.95e-06	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PIK3CA—prostate cancer	4.53e-07	5.93e-06	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PIK3CA—prostate cancer	4.53e-07	5.93e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CAV1—prostate cancer	4.53e-07	5.93e-06	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—AKT1—prostate cancer	4.5e-07	5.89e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3CD—prostate cancer	4.49e-07	5.87e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—LPL—prostate cancer	4.47e-07	5.84e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—MTHFR—prostate cancer	4.41e-07	5.77e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TP53—prostate cancer	4.4e-07	5.76e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CDKN1B—prostate cancer	4.38e-07	5.73e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	4.33e-07	5.66e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PPARA—prostate cancer	4.33e-07	5.66e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CYP1A1—prostate cancer	4.31e-07	5.64e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—MTHFR—prostate cancer	4.31e-07	5.63e-06	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PIK3CA—prostate cancer	4.29e-07	5.61e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ERCC2—prostate cancer	4.28e-07	5.6e-06	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PTEN—prostate cancer	4.26e-07	5.57e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PIK3CA—prostate cancer	4.24e-07	5.55e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—NOS3—prostate cancer	4.24e-07	5.54e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PPARA—prostate cancer	4.22e-07	5.52e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CTNNB1—prostate cancer	4.14e-07	5.41e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3CG—prostate cancer	4.13e-07	5.4e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CAV1—prostate cancer	4.07e-07	5.32e-06	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—EP300—prostate cancer	4.06e-07	5.31e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CDKN1A—prostate cancer	4.04e-07	5.29e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PTEN—prostate cancer	4.03e-07	5.28e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IL6—prostate cancer	4.03e-07	5.27e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—MTHFR—prostate cancer	4.02e-07	5.26e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CAV1—prostate cancer	3.97e-07	5.19e-06	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PIK3CA—prostate cancer	3.95e-07	5.16e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PPARA—prostate cancer	3.95e-07	5.16e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3CB—prostate cancer	3.91e-07	5.11e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—INS—prostate cancer	3.91e-07	5.11e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.89e-07	5.08e-06	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—AKT1—prostate cancer	3.89e-07	5.08e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—EP300—prostate cancer	3.85e-07	5.03e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CREBBP—prostate cancer	3.83e-07	5.01e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—IL6—prostate cancer	3.76e-07	4.91e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—SRC—prostate cancer	3.74e-07	4.89e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—AKT1—prostate cancer	3.72e-07	4.86e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CAV1—prostate cancer	3.71e-07	4.85e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3CG—prostate cancer	3.71e-07	4.85e-06	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—AKT1—prostate cancer	3.7e-07	4.84e-06	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—AKT1—prostate cancer	3.7e-07	4.84e-06	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PIK3CA—prostate cancer	3.68e-07	4.82e-06	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PIK3CA—prostate cancer	3.68e-07	4.82e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3CD—prostate cancer	3.63e-07	4.75e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3CG—prostate cancer	3.62e-07	4.73e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—STAT3—prostate cancer	3.61e-07	4.72e-06	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PIK3CA—prostate cancer	3.55e-07	4.64e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.54e-07	4.64e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—INS—prostate cancer	3.51e-07	4.59e-06	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—AKT1—prostate cancer	3.5e-07	4.58e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—AKT1—prostate cancer	3.46e-07	4.53e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CREBBP—prostate cancer	3.44e-07	4.49e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—NOS3—prostate cancer	3.43e-07	4.48e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—INS—prostate cancer	3.42e-07	4.48e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3CG—prostate cancer	3.38e-07	4.42e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PTEN—prostate cancer	3.38e-07	4.42e-06	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PIK3CA—prostate cancer	3.38e-07	4.41e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CREBBP—prostate cancer	3.35e-07	4.39e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MYC—prostate cancer	3.35e-07	4.38e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—TGFB1—prostate cancer	3.35e-07	4.37e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—EGFR—prostate cancer	3.28e-07	4.29e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3CD—prostate cancer	3.26e-07	4.26e-06	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—AKT1—prostate cancer	3.22e-07	4.22e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—EP300—prostate cancer	3.22e-07	4.21e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—INS—prostate cancer	3.2e-07	4.18e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3CD—prostate cancer	3.18e-07	4.16e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3CB—prostate cancer	3.16e-07	4.14e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PTGS2—prostate cancer	3.13e-07	4.1e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CREBBP—prostate cancer	3.13e-07	4.1e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—KRAS—prostate cancer	3.1e-07	4.05e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—NOS3—prostate cancer	3.08e-07	4.02e-06	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—AKT1—prostate cancer	3.01e-07	3.94e-06	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—AKT1—prostate cancer	3.01e-07	3.94e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—NOS3—prostate cancer	3e-07	3.93e-06	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PIK3CA—prostate cancer	3e-07	3.93e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3CD—prostate cancer	2.97e-07	3.89e-06	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—AKT1—prostate cancer	2.9e-07	3.79e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PIK3CA—prostate cancer	2.85e-07	3.72e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3CB—prostate cancer	2.84e-07	3.71e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PTGS2—prostate cancer	2.81e-07	3.68e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—NOS3—prostate cancer	2.81e-07	3.67e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3CB—prostate cancer	2.77e-07	3.62e-06	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—AKT1—prostate cancer	2.76e-07	3.61e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PTGS2—prostate cancer	2.75e-07	3.59e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PTEN—prostate cancer	2.73e-07	3.57e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—EP300—prostate cancer	2.61e-07	3.41e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3CB—prostate cancer	2.59e-07	3.39e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PTGS2—prostate cancer	2.57e-07	3.36e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—IL6—prostate cancer	2.52e-07	3.3e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PTEN—prostate cancer	2.45e-07	3.21e-06	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—AKT1—prostate cancer	2.45e-07	3.21e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PTEN—prostate cancer	2.4e-07	3.13e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3CA—prostate cancer	2.38e-07	3.12e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—EP300—prostate cancer	2.34e-07	3.06e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—AKT1—prostate cancer	2.33e-07	3.04e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—EP300—prostate cancer	2.28e-07	2.99e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PTEN—prostate cancer	2.24e-07	2.93e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—EP300—prostate cancer	2.13e-07	2.79e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—AKT1—prostate cancer	1.95e-07	2.55e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3CA—prostate cancer	1.93e-07	2.52e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3CA—prostate cancer	1.73e-07	2.26e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3CA—prostate cancer	1.69e-07	2.21e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3CA—prostate cancer	1.58e-07	2.06e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—AKT1—prostate cancer	1.58e-07	2.06e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—AKT1—prostate cancer	1.41e-07	1.85e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—AKT1—prostate cancer	1.38e-07	1.81e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—AKT1—prostate cancer	1.29e-07	1.69e-06	CbGpPWpGaD
